Analyst Ratings for Quest Diagnostics (DGX)
DGX Rating Summary
DGX Price Target Summary
- Highest: $260.00 (Morgan Stanley)
- Lowest: $200.00 (Piper Sandler)
- Average: $243.71
* Over Last 12-Mos
Overall Rating:
NEUTRAL
Rating Trend:
Avg. $ Target:
$243.71 (+3.7%)
* Over Last 12-Mos
Rating Score: 4.4 / 10
Percentile Rank: 44%
Avg. $ Target:
$243.71 (+3.7%)
* Over Last 12-Mos
Rating Score: 4.4 / 10
Percentile Rank: 44%
| Date | Firm | Analyst | Type | Rating (Past) |
PT (Past) |
Start $ (End $) |
% Chg. | Details |
|---|---|---|---|---|---|---|---|---|
| 2/2/2026 | Barclays » Updated 10/7/2026 |
Luke Sergott | Upgrade | Overweight (Equalweight) |
260.00 (250.00) |
182.35 (235.00) |
28.87% | Details |
| 8/25/2025 | Baird » Updated 9/22/2026 |
Eric Coldwell | Downgrade | Neutral (Outperform) |
260.00 (255.00) |
183.72 (235.00) |
27.91% | Details |
 |
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
